IN2014DN06965A - - Google Patents
Info
- Publication number
- IN2014DN06965A IN2014DN06965A IN6965DEN2014A IN2014DN06965A IN 2014DN06965 A IN2014DN06965 A IN 2014DN06965A IN 6965DEN2014 A IN6965DEN2014 A IN 6965DEN2014A IN 2014DN06965 A IN2014DN06965 A IN 2014DN06965A
- Authority
- IN
- India
- Prior art keywords
- relates
- pregabalin
- preparation
- pharmaceutically acceptable
- acrylic acid
- Prior art date
Links
- 229920002125 Sokalan® Polymers 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 abstract 1
- 229960001233 pregabalin Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN6965DEN2014 IN2014DN06965A (ru) | 2012-01-30 | 2013-01-29 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN249DE2012 | 2012-01-30 | ||
| IN6965DEN2014 IN2014DN06965A (ru) | 2012-01-30 | 2013-01-29 | |
| PCT/IB2013/050762 WO2013114281A1 (en) | 2012-01-30 | 2013-01-29 | Pregabalin gr tablets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN06965A true IN2014DN06965A (ru) | 2015-04-10 |
Family
ID=48014112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN6965DEN2014 IN2014DN06965A (ru) | 2012-01-30 | 2013-01-29 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20140378545A1 (ru) |
| EP (1) | EP2809303A1 (ru) |
| AU (1) | AU2013213859A1 (ru) |
| CA (1) | CA2863371A1 (ru) |
| IN (1) | IN2014DN06965A (ru) |
| WO (1) | WO2013114281A1 (ru) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102221846B1 (ko) * | 2014-04-07 | 2021-02-26 | 영진약품 주식회사 | 안정성이 개선된 프레가발린을 함유하는 약제학적 조성물 및 이의 제조방법 |
| CN108159011A (zh) * | 2018-03-16 | 2018-06-15 | 中国药科大学 | 一种双相控释的普瑞巴林胃滞留缓释片及其制备方法 |
| PL3760190T3 (pl) * | 2019-07-03 | 2023-09-04 | Alvogen, Inc. | Tabletki pregabaliny o kontrolowanym uwalnianiu, sposób wytwarzania i sposób ich zastosowania |
| TWI733299B (zh) * | 2020-01-07 | 2021-07-11 | 華宇藥品股份有限公司 | 普加巴林的持續-釋放配方 |
| CN113577036B (zh) * | 2021-05-31 | 2023-04-04 | 石药集团欧意药业有限公司 | 一种普瑞巴林胃漂浮缓释片及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6197819B1 (en) | 1990-11-27 | 2001-03-06 | Northwestern University | Gamma amino butyric acid analogs and optical isomers |
| US5869029A (en) * | 1996-06-21 | 1999-02-09 | Hercules Incorporated | Dispersible water-soluble or water-swellable polymers and process for making toothpastes containing them |
| KR100491282B1 (ko) | 1996-07-24 | 2005-05-24 | 워너-램버트 캄파니 엘엘씨 | 통증 치료용 이소부틸가바 및 그의 유도체 |
| NL2000281C2 (nl) | 2005-11-02 | 2007-08-07 | Pfizer Prod Inc | Vaste farmaceutische samenstellingen die pregabaline bevatten. |
| US8454993B2 (en) | 2007-11-23 | 2013-06-04 | Lupin Limited | Controlled release pharmaceutical compositions of pregabalin |
| EP2440190A1 (en) | 2009-06-12 | 2012-04-18 | Micro Labs Limited | Novel pharmaceutical compositions containing pregabalin |
| EP2389933A1 (en) * | 2010-05-25 | 2011-11-30 | Sanovel Ilac Sanayi ve Ticaret A.S. | Controlled-Release Pregabalin Compositions |
| WO2011151708A1 (en) | 2010-06-01 | 2011-12-08 | Rubicon Research Private Limited | Gastroretentive dosage forms of gaba analogs |
| US9393205B2 (en) * | 2012-01-30 | 2016-07-19 | Sun Pharmaceutical Industries Limited | Gastroretentive tablets |
-
2013
- 2013-01-29 CA CA2863371A patent/CA2863371A1/en not_active Abandoned
- 2013-01-29 IN IN6965DEN2014 patent/IN2014DN06965A/en unknown
- 2013-01-29 WO PCT/IB2013/050762 patent/WO2013114281A1/en active Application Filing
- 2013-01-29 EP EP13712904.5A patent/EP2809303A1/en not_active Withdrawn
- 2013-01-29 US US14/374,500 patent/US20140378545A1/en not_active Abandoned
- 2013-01-29 AU AU2013213859A patent/AU2013213859A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013114281A1 (en) | 2013-08-08 |
| AU2013213859A1 (en) | 2014-08-21 |
| EP2809303A1 (en) | 2014-12-10 |
| CA2863371A1 (en) | 2013-08-08 |
| US20140378545A1 (en) | 2014-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN06966A (ru) | ||
| PH12015500561A1 (en) | Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same | |
| CL2013000028S1 (es) | Conector | |
| MX2014004862A (es) | Formulaciones de polimero acrilico. | |
| MX364229B (es) | Composiciones y metodos para tratar enfermedades cardiovasculares. | |
| MX346789B (es) | Metodo para producir preparaciones farmaceuticas con contenido de inhibidores de la bomba de protones (ibp). | |
| PH12018501072A1 (en) | Modified release orally administered amino acid formulations | |
| EP3102188A4 (en) | Novel disintegration systems for pharmaceutical dosage forms | |
| IN2014DN06965A (ru) | ||
| MX2016005477A (es) | Formas de dosificacion disuasivas del abuso. | |
| EA201692043A1 (ru) | Лекарственная форма иммунодепрессанта | |
| EP3102585A4 (en) | Boronic acid esters and pharmaceutical formulations thereof | |
| PH12014502856B1 (en) | Solid pharmaceutical preparation containing levothyroxine | |
| MX2016006087A (es) | Formulaciones de desintegracion rapida y metodos de uso. | |
| MX2017000497A (es) | Detergente en tableta para lavavajillas y metodos de fabricacion y de utilizacion del mismo. | |
| MX2017007245A (es) | Metodos de tratamiento de la fibrosis. | |
| MX2014009871A (es) | Formulacion farmaceutica que tiene estabilidad mejorada. | |
| PH12014502325B1 (en) | Sustained release tablet containing levodropropizine and method for preparing same | |
| MX2015008171A (es) | Formulacion que comprende agomelatina amorfa. | |
| IN2014DN07191A (ru) | ||
| WO2016137266A3 (ko) | 에페리손과 펠루비프로펜을 함유하는 약제학적 조성물 | |
| MX2017006561A (es) | Formulaciones farmaceuticas de matriz comprenden dimetilfumarato. | |
| WO2014013090A3 (en) | Formulation comprising amorphous fingolimod | |
| IN2014MU00215A (ru) | ||
| WO2013115736A3 (en) | Bilayer tablet formulations of flurbiprofen and glucosamin |